Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
Uro · 2021
DOI: 10.3390/uro1030012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Uro, 2021. Verfasst von Antonio La Torre und 12 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 238 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This is a critical review of the current literature data about sexual dysfunction as a potential side effect related to drugs commonly used for the treatment of Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms. In this narrative review, we analyzed data from the literature related to the development of sexual dysfunctions during the treatment of BPH or LUTS. Both α-blockers and 5-alpha reductase inhibitors (5-ARIs) can induce erectile dysfunction, ejaculatory disorders and a reduction in sexual desire. The sexual side effect profile of these drugs is different. Among the α-blockers, silodosin appears to have the highest incidence of ejaculatory disorders. Persistent sexual side effects after the discontinuation of finasteride have been recently reported; however, further studies are needed to clarify the true incidence and the significance of this finding. However, most of the published studies are affected by a weak methodology and other important limitations, with only a few RCTs available. Therefore, it is desirable that future studies will include validated tools to assess and diagnose the sexual dysfunction induced by these medications, especially for ejaculation and sexual desire disorders.
Zitieren
APA
Torre, A. L., Palleria, C., Tamanini, I., Scardigli, A., Cai, T., Colosimo, M., Muraca, L., Rania, V., Mirra, D., Casarella, A., Marcianò, G., Sarro, G. D., & Gallelli, L. (2021). Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors. Uro. https://doi.org/10.3390/uro1030012
Vancouver
Torre AL, Palleria C, Tamanini I, Scardigli A, Cai T, Colosimo M, et al. Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors. Uro. 2021. doi:10.3390/uro1030012
BibTeX
@article{Torre2021,
author = {Torre, Antonio La and Palleria, Caterina and Tamanini, Irene and Scardigli, Andrea and Cai, Tommaso and Colosimo, Manuela and Muraca, Lucia and Rania, Vincenzo and Mirra, Davida and Casarella, Alessandro and Marcianò, Gianmarco and Sarro, Giovambattista De and Gallelli, Luca},
title = {Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors},
journal = {Uro},
year = {2021},
doi = {10.3390/uro1030012}
}
EUVIMED